Robinson Cole LLP
High Contrast Mode
Marquee

Enforcement, Investigations + Litigation in Health Care

Government and regulatory agencies have made detecting and prosecuting fraud, waste, and abuse a centerpiece of their enforcement efforts. The stakes are high, and government investigations are often bet-the-company endeavors. Robinson+Cole’s Health Care Enforcement + False Claims Act Litigation team has the experience and resources necessary to guide clients through government investigations and the defense of companies and individuals in civil and criminal enforcement matters.

Our Services

Our Health Care Enforcement + False Claims Act Litigation practice comprises a multidisciplinary group of attorneys who seamlessly work together to address our clients’ needs from various perspectives. We have health law, white-collar defense, litigation, and employment lawyers with significant experience in discretely conducting internal investigations and developing compliance plans to mitigate risk before the government becomes involved. And when government investigations arise, we have substantive experience defending companies in enforcement actions, negotiating resolutions, and aggressively litigating civil and criminal matters in federal and state courts.

We represent health care companies in federal and state civil and criminal investigations and litigation nationwide. We have represented clients before the Criminal and Civil divisions of the U.S. Department of Justice, U.S. Attorney’s Offices, the U.S. Department of Health and Human Services Office of Inspector General, the Centers for Medicare & Medicaid Services, state Medicaid Fraud Control Units, and state attorneys general offices throughout the country.

We defend a variety of health care providers, including clinical laboratories, medical device manufacturers, remote patient monitoring providers, durable medical equipment providers, hospitals, home health care agencies, physicians, pharmacies, and telehealth providers. We work with clients on all aspects of enforcement matters, responding to search warrants and civil investigative demands through resolution or trial. Member of our team have convinced prosecutors to decline cases and have successfully resolved many others through settlements that were favorable to our clients. We often handle parallel investigations involving civil litigation, administrative actions, and criminal investigations.

We have notable experience defending against allegations of offering or receiving kickbacks in violation of the Anti-Kickback Statute (AKS), violations of the Eliminating Kickbacks in Recovery Act (EKRA), unlawful financial relationships and self-referrals in violation of the Stark Law, filing false claims with government health care programs in violation of the False Claims Act, and receiving overpayments from government health care payors.

Our Team

Our attorneys have a wide variety of government and health care backgrounds and bring their varied enforcement experience to bear through a multidisciplinary approach. We actively speak and write about enforcement trends in the health care industry and participate in professional organizations that bring government and defense attorneys together.

Experience

Represented MD Labs in First Circuit Victory for Clinical Lab in False Claims Act Appeal

Successfully represented MD Labs and its owners in defending against False Claims Act allegations in U.S. ex rel. Omni Healthcare Inc. v. MD Spine Solutions LLC et al., securing summary judgment in the District of Massachusetts and a unanimous affirmation by the U.S. Court of Appeals for the First Circuit. This landmark decision clarified that clinical laboratories may rely on doctor’s orders to show that the test is “reasonable and necessary” and confirmed that commissions to independent contractors are not per se illegal — setting an important precedent for clinical laboratories nationwide.

Read More
Represented MD Labs in First Circuit Victory for Clinical Lab in False Claims Act Appeal

Publications

Keeping Cool When ICE Arrives: Basic Raid Response Strategies for Laboratories teaser
November 17, 2025

Keeping Cool When ICE Arrives: Basic Raid Response Strategies for Laboratories

The ColLABorative Brief
July 30, 2025

From Red Flags to Readiness: How Labs Can Stay Ahead of Audit Risks

Quadax Blog

With $1.2B in improper lab payments projected, payers are ramping up audits—putting clinical labs under intense scrutiny. In our recent webinar, Labs Under the Microscope: Staying Ready for Payer Audits, Ann Betzel (AVP of Client Engagement at Quadax) and I shared practical strategies to help labs stay ahead of audit risks—covering what triggers payer scrutiny, what auditors are really looking for, and how to ask the right questions of your revenue cycle management vendors. Why Payer Audits Are Targeting Labs Labs are currently the most audited healthcare sector, due to billing complexities and a high volume of claims submitted with insufficient documentation. They also had the highest projected improper payments across all healthcare service types. That puts a target on your back. Audit activity includes: Medicare TPE (Targeted Probe and Educate) audits UPIC (Unified Program Integrity Contractor) investigations RAC (Recovery Audit Contractor) reviews Commercial payer audits based on data mining and AI tools These reviews focus on trends like test frequency, missing requisition signatures, incorrect coding, and a lack of clear medical necessity which can trigger recoupment or billing suspensions. Common Audit Triggers for Clinical Labs Auditors are increasingly relying on data analytics and artificial intelligence to flag outliers. Labs may be selected for audits if they show: High utilization of uncommon lab codes Incomplete or unsigned test requisition forms Missing documentation for medical necessity Sudden spikes in volume or billing patterns Tests ordered outside payer policy guidelines (e.g., MolDX, LCDs) “We’re seeing insufficient documentation and missing medical necessity across the board,” shared Ann Betzel. “Labs rely on providers to supply this information, but if it’s missing or vague, it creates a significant compliance risk.” How to Respond When Audits Happen When a lab receives an audit request or ADR (Additional Documentation Request), how you respond can directly impact financial and legal outcomes. I recommend using a detailed, structured approach: Tell the reviewer exactly where the order is, where medical necessity is supported, and how the results were used in treatment. Make sure to confirm that all required documentation—such as test orders, results, and proof of medical necessity—is complete and accurate before submission. Take time to review the specific policy requirements of the payer to ensure compliance. When responding to an audit, include a cover letter that clearly walks through the supporting evidence to help guide the reviewer. If additional time is needed to collect documentation, don’t hesitate to request an extension. Most importantly, use the audit process as an opportunity to evaluate your broader billing and documentation practices for potential gaps or systemic issues. Build an Audit-Resilient Revenue Cycle The best way to avoid audit penalties is to stay audit-ready. That means: ✅ Conducting regular internal audits on lab billing workflows ✅ Educating provider clients on payer documentation standards ✅ Monitoring denials to identify patterns or payer policy changes ✅ Using data analytics to assess billing trends and reduce risk ✅ Staying up-to-date on Medicare, MolDX, and commercial payer guidelines Watch the Full Webinar Interested in learning more? You can access the full session recording here, Labs Under the Microscope: Staying Ready for Payer Audits. Re-published from the Quadax Blog.

Keeping Cool When ICE Arrives: Basic Raid Response Strategies for Laboratories teaser
November 17, 2025

Keeping Cool When ICE Arrives: Basic Raid Response Strategies for Laboratories

The ColLABorative Brief
July 30, 2025

From Red Flags to Readiness: How Labs Can Stay Ahead of Audit Risks

Quadax Blog

With $1.2B in improper lab payments projected, payers are ramping up audits—putting clinical labs under intense scrutiny. In our recent webinar, Labs Under the Microscope: Staying Ready for Payer Audits, Ann Betzel (AVP of Client Engagement at Quadax) and I shared practical strategies to help labs stay ahead of audit risks—covering what triggers payer scrutiny, what auditors are really looking for, and how to ask the right questions of your revenue cycle management vendors. Why Payer Audits Are Targeting Labs Labs are currently the most audited healthcare sector, due to billing complexities and a high volume of claims submitted with insufficient documentation. They also had the highest projected improper payments across all healthcare service types. That puts a target on your back. Audit activity includes: Medicare TPE (Targeted Probe and Educate) audits UPIC (Unified Program Integrity Contractor) investigations RAC (Recovery Audit Contractor) reviews Commercial payer audits based on data mining and AI tools These reviews focus on trends like test frequency, missing requisition signatures, incorrect coding, and a lack of clear medical necessity which can trigger recoupment or billing suspensions. Common Audit Triggers for Clinical Labs Auditors are increasingly relying on data analytics and artificial intelligence to flag outliers. Labs may be selected for audits if they show: High utilization of uncommon lab codes Incomplete or unsigned test requisition forms Missing documentation for medical necessity Sudden spikes in volume or billing patterns Tests ordered outside payer policy guidelines (e.g., MolDX, LCDs) “We’re seeing insufficient documentation and missing medical necessity across the board,” shared Ann Betzel. “Labs rely on providers to supply this information, but if it’s missing or vague, it creates a significant compliance risk.” How to Respond When Audits Happen When a lab receives an audit request or ADR (Additional Documentation Request), how you respond can directly impact financial and legal outcomes. I recommend using a detailed, structured approach: Tell the reviewer exactly where the order is, where medical necessity is supported, and how the results were used in treatment. Make sure to confirm that all required documentation—such as test orders, results, and proof of medical necessity—is complete and accurate before submission. Take time to review the specific policy requirements of the payer to ensure compliance. When responding to an audit, include a cover letter that clearly walks through the supporting evidence to help guide the reviewer. If additional time is needed to collect documentation, don’t hesitate to request an extension. Most importantly, use the audit process as an opportunity to evaluate your broader billing and documentation practices for potential gaps or systemic issues. Build an Audit-Resilient Revenue Cycle The best way to avoid audit penalties is to stay audit-ready. That means: ✅ Conducting regular internal audits on lab billing workflows ✅ Educating provider clients on payer documentation standards ✅ Monitoring denials to identify patterns or payer policy changes ✅ Using data analytics to assess billing trends and reduce risk ✅ Staying up-to-date on Medicare, MolDX, and commercial payer guidelines Watch the Full Webinar Interested in learning more? You can access the full session recording here, Labs Under the Microscope: Staying Ready for Payer Audits. Re-published from the Quadax Blog.

News

April 22, 2026

Danielle Tangorre Explains Significance of Groundbreaking Decision for Clinical Laboratories

Health Care Enforcement + False Claims Act Litigation team member Danielle Tangorre spoke with The Dark Report and G2 Intelligence about the significance of the U.S. Court of Appeals for the First Circuit  in U.S. ex rel OMNI Healthcare v. MD Spine Solutions LLC, et al that came down in December 2025. The decision affirmed a lower court’s dismissal of a “high stakes” False Claims Act lawsuit, providing clarity for the diagnostic laboratory industry. Danielle, along with team members Edward J. Heath and Seth B. Orkand, represented MD Labs in the appeals case. Covering the decision from a legal risk perspective, The Dark Report said, “this decision creates a new 'safe harbor' for medical necessity while defining the specific boundaries where that protection ends.” Danielle explained the decision enshrined that “clinical laboratories can generally rely on a physician’s order as evidence that testing is reasonable and necessary…[T]hat’s significant because labs bill for tests but do not treat patients. They rely on the physician’s clinical judgment.” Danielle noted, however, that the relationship is collaborative and labs also have a corollary duty. Danielle also highlighted how the decision shifted the burden of proof, as the First Circuit Court focused specifically on the intent required for a lab to be held liable for fraud. “The court also clarified that if a lab relies on a physician’s order, the burden shifts to the relator to show the lab should not have relied on it—for example, if the lab influenced or usurped the physician’s decision-making,” said Tangorre. “That’s a major takeaway for laboratories.” Because Circuit Court rulings are often cited by other courts across the country, the decision provides a defensive blueprint for labs facing similar allegations. The decision “provides clarity on how courts view a lab’s role in certifying medical necessity while relying on physicians,” Danielle said.  “It essentially gives labs guardrails: Labs can rely on physician orders, but here’s where you can run into trouble. Organizations that operate cohesively and not in silos are in the best position to manage risk,” Danielle concluded. G2 Intelligence’s "Lab Industry Advisor,” another leading publication for the clinical lab industry examined the decision by focusing on compliance elements of the case. The article said a practical takeaway from the case for clinical lab directors involves the design of test requisition forms. “The courts emphasized that MD Labs did not improperly design its requisition. That’s an important lesson. Labs need to ensure requisitions are not steering or influencing test selection,” Danielle warned. “The same applies to marketing. Overpromising test value or implying broader clinical utility than supported can create risk, even if labs can generally rely on physician orders.” While the appellate ruling focused on medical necessity, it allowed the lower court’s findings on independent contractor commissions to stand. The clinical lab industry has long assumed that paying commissions to independent sales agents is “per se” violation of the Anti-Kickback Statue or the Eliminating Kickbacks in Recovery Act. The MD Labs case suggests that context and compliance matter most. “Importantly, the relator did not appeal the independent contractor issue, so the finding that commission payments are not inherently illegal stands,” Danielle pointed out. “That aligns with a growing trend in the courts: Sales commissions are not automatically violations of AKS or EKRA unless there is some additional improper conduct—what I call a ‘plus factor’—such as influencing ordering behavior.” The court was persuaded by the fact that MD Labs had a robust compliance framework, Danielle said. “Independent contractors were treated similarly to employees, and compliance oversight was robust,” she added. “That’s critical.”

Dark Report
G2 Intelligence’s Lab Industry Advisor
December 4, 2025

Health Care Enforcement Team Secures First Circuit Win for Clinical Lab in False Claims Act Appeal

January 27, 2025

Health Care Enforcement Team Wins Summary Judgment in Groundbreaking False Claims Act Litigation

Law.com, Law360, G2 Intelligence, The Dark Report, Laboratory Economics, and Massachusetts Lawyers Weekly
April 22, 2026

Danielle Tangorre Explains Significance of Groundbreaking Decision for Clinical Laboratories

Health Care Enforcement + False Claims Act Litigation team member Danielle Tangorre spoke with The Dark Report and G2 Intelligence about the significance of the U.S. Court of Appeals for the First Circuit  in U.S. ex rel OMNI Healthcare v. MD Spine Solutions LLC, et al that came down in December 2025. The decision affirmed a lower court’s dismissal of a “high stakes” False Claims Act lawsuit, providing clarity for the diagnostic laboratory industry. Danielle, along with team members Edward J. Heath and Seth B. Orkand, represented MD Labs in the appeals case. Covering the decision from a legal risk perspective, The Dark Report said, “this decision creates a new 'safe harbor' for medical necessity while defining the specific boundaries where that protection ends.” Danielle explained the decision enshrined that “clinical laboratories can generally rely on a physician’s order as evidence that testing is reasonable and necessary…[T]hat’s significant because labs bill for tests but do not treat patients. They rely on the physician’s clinical judgment.” Danielle noted, however, that the relationship is collaborative and labs also have a corollary duty. Danielle also highlighted how the decision shifted the burden of proof, as the First Circuit Court focused specifically on the intent required for a lab to be held liable for fraud. “The court also clarified that if a lab relies on a physician’s order, the burden shifts to the relator to show the lab should not have relied on it—for example, if the lab influenced or usurped the physician’s decision-making,” said Tangorre. “That’s a major takeaway for laboratories.” Because Circuit Court rulings are often cited by other courts across the country, the decision provides a defensive blueprint for labs facing similar allegations. The decision “provides clarity on how courts view a lab’s role in certifying medical necessity while relying on physicians,” Danielle said.  “It essentially gives labs guardrails: Labs can rely on physician orders, but here’s where you can run into trouble. Organizations that operate cohesively and not in silos are in the best position to manage risk,” Danielle concluded. G2 Intelligence’s "Lab Industry Advisor,” another leading publication for the clinical lab industry examined the decision by focusing on compliance elements of the case. The article said a practical takeaway from the case for clinical lab directors involves the design of test requisition forms. “The courts emphasized that MD Labs did not improperly design its requisition. That’s an important lesson. Labs need to ensure requisitions are not steering or influencing test selection,” Danielle warned. “The same applies to marketing. Overpromising test value or implying broader clinical utility than supported can create risk, even if labs can generally rely on physician orders.” While the appellate ruling focused on medical necessity, it allowed the lower court’s findings on independent contractor commissions to stand. The clinical lab industry has long assumed that paying commissions to independent sales agents is “per se” violation of the Anti-Kickback Statue or the Eliminating Kickbacks in Recovery Act. The MD Labs case suggests that context and compliance matter most. “Importantly, the relator did not appeal the independent contractor issue, so the finding that commission payments are not inherently illegal stands,” Danielle pointed out. “That aligns with a growing trend in the courts: Sales commissions are not automatically violations of AKS or EKRA unless there is some additional improper conduct—what I call a ‘plus factor’—such as influencing ordering behavior.” The court was persuaded by the fact that MD Labs had a robust compliance framework, Danielle said. “Independent contractors were treated similarly to employees, and compliance oversight was robust,” she added. “That’s critical.”

Dark Report
G2 Intelligence’s Lab Industry Advisor
December 4, 2025

Health Care Enforcement Team Secures First Circuit Win for Clinical Lab in False Claims Act Appeal

January 27, 2025

Health Care Enforcement Team Wins Summary Judgment in Groundbreaking False Claims Act Litigation

Law.com, Law360, G2 Intelligence, The Dark Report, Laboratory Economics, and Massachusetts Lawyers Weekly

Events

Past

Under OIG Scrutiny: Translating 2025 Enforcement Trends Into Actionable Strategies for Laboratory Compliance, Test Utilization Optimization, and Enterprise-Wide Risk Mitigation in 2026

Apr 28 2026
2026 Executive War College
Past

The Slippery Slope to Enforcement: How Payor Audits Trigger Government Action—and How to Identify Compliance Risk Early

Apr 28 2026
2026 Executive War College
Past

Under OIG Scrutiny: Translating 2025 Enforcement Trends Into Actionable Strategies for Laboratory Compliance, Test Utilization Optimization, and Enterprise-Wide Risk Mitigation in 2026

Apr 28 2026
2026 Executive War College
Past

The Slippery Slope to Enforcement: How Payor Audits Trigger Government Action—and How to Identify Compliance Risk Early

Apr 28 2026
2026 Executive War College
Past

Recent Health Care Enforcement Trends for Clinical Laboratories, Durable Medical Equipment Suppliers and Remote Patient Monitoring Providers

Oct 9 2025
2025 AHLA Fraud and Compliance Forum
Past

Recent Health Care Enforcement Trends for Clinical Laboratories, Durable Medical Equipment Suppliers and Remote Patient Monitoring Providers

Oct 9 2025
2025 AHLA Fraud and Compliance Forum

Firm Highlights

News
Robinson+Cole Names J. Michael Wirvin as Managing Partner

Robinson+Cole’s partnership has elected Boston Business Transactions Partner J. Michael Wirvin as its next Managing Partner, marking a pivotal moment in the firm’s 180-year history. Effective March 1, Wirvin will become the firm’s first Managing Partner based outside of Hartford, CT, reflecting Robinson+Cole’s continued evolution and expanding geographic footprint. His election underscores the firm’s deliberate, forward‑looking approach to leadership succession and long‑term strategic growth. Wirvin has served on Robinson+Cole’s Managing Committee since 2014, where he has played a central role in firm governance, strategic planning, and leadership succession, working closely with three managing partners through periods of unprecedented growth, market expansion, and changes in the legal industry. He is widely recognized for advising clients on complex domestic and cross‑border mergers and acquisitions, financings, and corporate structuring matters, with a particular focus on assisting U.S. and offshore companies navigate the legal, commercial, and cultural complexities of operating across jurisdictions. Wirvin also co‑chairs the firm’s International team. Wirvin has served as partner-in-charge of Robinson+Cole’s Boston office since 2014, reinforcing the firm’s culture, mentoring lawyers at all stages of their careers, and fostering cross‑disciplinary teamwork that strengthens client service. He recently helped lead the relocation of Robinson+Cole’s Boston office to 53 State Street, a premier downtown tower, creating a modern, light‑filled space designed to support employee well‑being with an energizing environment along with enhanced technology and workspaces that facilitate seamless remote and on-site collaboration and team building, while also promoting focused work. “It is a profound honor to be elected by my partners to serve as Managing Partner and lead this extraordinary team of lawyers and business professionals who raise the bar every day,” said Wirvin. “Our 180-year history is defined not merely by longevity, but by the trust we have earned, the results we have delivered, and the professionalism, mutual respect, and collegiality that have long defined our culture. As Managing Partner, I aim to build on that foundation—bringing strategic clarity and disciplined growth to our priorities, strengthening our national and international profile, investing in our people, and ensuring Robinson+Cole remains agile, cohesive, and well positioned to deliver practical, business‑minded solutions for clients in an increasingly complex and competitive environment.” Wirvin succeeds Rhonda J. Tobin, the firm’s first female Managing Partner, who led Robinson+Cole since 2021 and guided the firm through a period of significant transformation, growth, and innovation. Elected during the height of the COVID‑19 pandemic, Tobin brought to the role more than a decade of firm leadership experience, including service on the Managing Committee for 17 years and leadership of the firm’s Litigation Section for 14 years. During Tobin’s five-year tenure, Robinson+Cole successfully advanced and executed on a new Strategic Plan, improving profitability; expanding the firm’s New York, Boston, and Philadelphia offices; opening and growing offices in Washington, DC, and Austin, TX; and deepening leading national practices in affordable housing finance, bankruptcy, business transactions, capital markets and securities, intellectual property and technology, health care, managed care litigation, immigration, insurance, public finance, and real estate and development. Under Tobin’s leadership, the firm also strengthened its commitment to collaboration, inclusion, and talent development; launched meaningful DEIB initiatives; and made significant investments in technology, information governance, and workplace innovation. Additionally, the firm achieved top national rankings in Vault’s Best Law Firms to Work For six consecutive years. Robinson+Cole became the first Am Law 200 firm to strategically partner with agentic AI builder Newcode.ai and the first law firm in the United States to earn ARMA’s Verified Organization status, further reinforcing its position as an industry leader in innovation and information governance. Tobin’s leadership has been widely recognized, including being named Regional Managing Partner of the Year in Law.com’s 2025 New England Legal Awards and Managing Partner of the Year in the 2022 Women, Influence & Power in Law Awards. She will continue to serve as chair of the firm’s lateral growth committee and will continue her leadership roles and active involvement in Connecticut’s non-profit community and as Chairperson of the Connecticut Judicial Review Council. Commenting on Wirvin’s election, Tobin stated, “Mike’s deeply rooted presence and extensive leadership experience at Robinson+Cole make him an outstanding choice to lead our firm. I have known and worked closely with Mike for more than two decades, and there is no question that he is the right person to guide us forward as technological advancements and an evolving professional landscape present new opportunities. Mike is an exceptionally talented and experienced lawyer, and a trusted confidant whose insight I consistently relied on when facing strategic decisions. He is deeply respected by our lawyers and business professionals and brings a thoughtful, strategic perspective that will greatly benefit the firm. I look forward to the firm’s continued growth and success under his leadership.” Robinson+Cole also announced several additional leadership updates reflecting the firm’s continued focus on thoughtful succession planning, geographic expansion, and strategic growth. Davis Lee Wright, who is based in the firm’s Wilmington office, has been elected to the Managing Committee, joining Britt‑Marie K. Cole‑Johnson and Edward J. Heath who are resident in the Hartford office, Eric M. Kogan in Stamford, and Charles F. Martin III in Miami. The firm recently named New York partner Erica J. Kerstein as chair of its Insurance + Reinsurance group, Stamford partner Patrick W. Begos co-chair of its Managed Care + ERISA Litigation group, and Hartford partners  Conor O. Duffy and Robert S. Melvin and as Health Law group co-chair and Land Law Section co-chair, respectively. In addition, Kendra L. Berardi will succeed Wirvin as partner in charge of the Boston office.

News
Robinson+Cole Recognized Across Practices and Regions with 46 Chambers USA 2026 Rankings
News
Robinson+Cole Expands National Platform with Four Lateral Partners

Robinson+Cole announced the addition of four lateral partners—J. Zachary Balasko, Eric Del Pozo, Brya M. Keilson and Victor R. Salgado, accelerating the firm’s continued investment in the growth of its national bankruptcy and business litigation capabilities. Balasko and Keilson join the firm’s Bankruptcy + Reorganizations group in Washington, DC, and Wilmington, DE, respectively, while Del Pozo and Salgado join the Business Litigation group in Hartford, CT, and Washington, DC. These strategic hires enhance the firm’s ability to serve clients navigating complex, high‑stakes bankruptcy, restructuring, government enforcement, and related litigation matters nationwide and expand the firm’s depth and reach across key markets. “These additions meaningfully reinforce the depth and versatility of our business litigation and restructuring platform and reflect a deliberate approach to strengthening these areas in ways that directly benefit our clients,” said J. Michael Wirvin, the firm’s Managing Partner. “Eric, Zak, Brya, and Victor each bring sophisticated experience and sound judgment that enhance our ability to advise clients through some of their most critical and challenging matters. Their arrival reflects our continued focus on building cohesive, multi-disciplinary teams with capabilities that extend across multiple markets.” J. Zachary Balasko joins the firm as a Bankruptcy + Reorganizations partner based in Washington, DC. His practice focuses on complex Chapter 11 cases and bankruptcy‑related litigation across the country, representing debtors, secured creditors, creditors’ committees, and governmental entities. Balasko brings substantial experience from both private practice and prior service with the U.S. Department of Justice, where he handled major insolvency matters involving federal interests. Eric Del Pozo joins Robinson+Cole’s Hartford, CT office as a Business Litigation partner focusing on complex commercial litigation and appellate matters, representing businesses and public entities in regulated industries in high-stakes and sophisticated disputes. Del Pozo brings experience from senior roles in government and private practice, where he has represented clients at both the trial and appellate levels. Brya Keilson joins Robinson+Cole as a Bankruptcy + Reorganizations partner in the firm’s Wilmington, DE office, one of the nation’s leading venues for complex bankruptcy proceeding . She represents debtors, creditors, committees, trustees, and other parties in interest in sophisticated Chapter 11 and Chapter 7 cases. Keilson is widely experienced in contested bankruptcy matters and frequently advises clients on both strategic and practical considerations throughout the restructuring process. Victor Salgado joins Robinson+Cole as a Business Litigation partner in the firm’s Washington, DC office. He brings significant experience from both government and private practice, including eight years as a federal prosecutor with the U.S. Department of Justice in Washington, DC, where he handled high‑profile and complex cases focusing on public corruption as well as crimes involving financial institutions. Salgado will also work closely with the firm’s Bankruptcy + Reorganizations group on contested matters arising in complex restructurings and related litigation. In addition, Destiney Parker-Thompson joins the firm as a Bankruptcy + Reorganizations associate in the Wilmington office. Parker‑Thompson focuses her practice on bankruptcy, restructuring, and related litigation matters, drawing on experience representing debtors, creditors, and financial institutions in complex Chapter 11 cases. She previously served as a judicial law clerk to the U.S. Bankruptcy Court for the District of Delaware and the U.S. Court of Appeals for the Third Circuit, bringing valuable insight to sophisticated restructuring matters. Robinson+Cole’s Bankruptcy + Reorganizations group has recently been recognized for its role in several of the most complex and precedent‑setting restructuring matters in the country, earning multiple national honors for its work in high‑profile Chapter 11 cases and related litigation. The group has guided stakeholders through landmark proceedings—including award‑recognized reorganizations, a first‑of‑its‑kind bankruptcy confirmed with a Section 524(g) injunction, and other transformative restructurings—reflecting the team’s ability to deliver strategic, results‑driven counsel in matters with significant legal and financial implications.

News
Robinson+Cole Integrates Thomson Reuters’ Deep Research into Newcode.ai Platform to Advance Secure, Verifiable Legal Research

Robinson+Cole has expanded its firmwide artificial intelligence (AI) capabilities by integrating Thomson Reuters’ Deep Research directly into Newcode.ai, the agentic AI platform implemented last year by the firm to support legal workflows across practices. With this integration, Robinson+Cole is one of only two law firms with direct access to the Deep Research API—and the only firm deploying it through Newcode.ai. Building on its 2025 partnership with Newcode.ai —making Robinson+Cole the first Am Law 200 firm to adopt the platform—the firm has continued to expand its AI capabilities as part of a broader strategy focused on secure deployment, ethical use, and seamless integration into daily legal work. The integration enables Robinson+Cole attorneys to conduct complex, multi‑step legal research and receive verifiable, citation‑backed responses grounded in trusted Thomson Reuters content. By embedding Deep Research into Newcode.ai, Robinson+Cole continues to build on its deliberate, governance‑first approach to AI adoption while delivering meaningful, practice‑ready innovation for its lawyers and clients. “Innovation at Robinson+Cole is grounded in client service, security, and practicality,” said J. Michael Wirvin, Managing Partner of Robinson+Cole. “By incorporating Thomson Reuters’ Deep Research directly into Newcode.ai, we are providing our lawyers with advanced research capabilities in a secure environment fully controlled by the firm that aligns with our standards for data governance, accuracy, and responsible AI use. This integration reflects our continued focus on adopting technology thoughtfully to support our attorneys and deliver value to our clients.” The addition of Deep Research allows attorneys to: Perform sophisticated legal research using agentic workflows that mirror real‑world legal reasoning Receive structured, verifiable responses grounded in Thomson Reuters data Streamline research processes while maintaining rigorous quality and accuracy standards Work entirely within Robinson+Cole’s firm‑controlled AI environment  “Our integration of the Thomson Reuters’ Deep Research API with Newcode represents a defining moment in our AI strategy,” said Chief Data Officer Jim Merrifield. "We are incredibly proud to be the first firm to bring this capability to life—unlocking the power of trusted legal data directly within the workflows our lawyers and business professionals rely on every day. This is exactly how we maximize our technology investments: by connecting best-in-class data sources through APIs into a unified platform, so the technology meets our people where they work, enhances their judgment, and accelerates better outcomes for our clients.” Robinson+Cole’s AI program is guided by firmwide policies, mandatory training, and ongoing oversight to ensure responsible use of emerging technologies. The firm’s approach emphasizes measured adoption, strong information governance, and alignment with client expectations, rather than one‑off experimentation. This latest enhancement underscores Robinson+Cole’s commitment to remaining forward‑thinking in its use of technology, while ensuring that innovation serves the firm’s clients, lawyers, and long‑term strategic goals.

News
Robinson+Cole’s People-First Culture Recognized in Vault’s 2027 Rankings
News
Robinson+Cole Recognized at 2026 Women, Influence & Power in Law Awards
News
Julianna Charpentier Recognized as an “Up & Coming Lawyer”
News
Erica Kerstein Brings Credibility and Business Perspective to New Role as Practice Group Chair

Insurance + Reinsurance group chair Erica J. Kerstein was featured in a Law.com column titled, “How I Made Practice Group Chair,” published on April 15, 2026. In the article, Erica discusses her new role as a practice group chair and how it has expanded her insight into not only the firm’s strategic vision and goals, but the reality of running a business and ensuring that current planning aligns with future goals. “The role provides a window into how individual practices fit into the firm’s overall strategy,” said Erica. “You’re thinking not just about today’s matters, but about where clients are headed, how the industry is changing, and how the firm positions itself to meet those needs.” In addition, Erica also identified “…strengthening client relationships, investing in our people, and staying ahead of emerging issues—particularly around technology and artificial intelligence in the insurance space…” as key priorities for the practice. Read the article.

News
Robinson+Cole Remains A “Best Place to Work in Connecticut”
News
Kate Dion and Natale DiNatale Examine the Legal Questions Raised By Sorsby Injunction

Education industry team chair Kathleen Dion and Labor Relations group chair Natale DiNatale discussed the potential ramifications on the NCAA and college athletes in the article, “NCAA to appeal Brendan Sorsby injunction. What it means and how it can win,” published in USA Today, June 8, 2026. Kate pointed out that the injunction is a temporary measure. “This decision is only a preliminary ruling and is subject to appeal. Unless it is overturned, the injunction preserves Sorsby’s opportunity to compete this fall while the underlying case proceeds and allows him to continue preparing for a potential NFL career. For the NCAA, the ruling raises questions about the extent to which courts may review and potentially limit the enforcement of eligibility and competitive-integrity rules in individual cases.”  She continued, “It is also important to recognize that this is one state trial court decision, not a final decision on the merits, and thus its precedential value may be limited. While the court found that Sorsby demonstrated a probable right to the relief that he seeks on his breach of contract and other claims, which is a necessary element for obtaining a temporary injunction — the order does not appear to provide a detailed explanation of the court’s reasoning on that issue. As a result, many of the legal questions raised by the case are likely to remain the subject of further litigation and possible appellate review.” Discussing the foundation of the claim, Natale said, “The underlying dispute looks like a claim that the NCAA failed to accommodate a disability (e.g. an ADA claim based on a gambling addiction). But, it was brought as a breach of contract claim. A contract claim can be brought and maybe kept, in state court, which is likely a friendlier forum for this athlete.” Read the article.

News
Robinson+Cole Names J. Michael Wirvin as Managing Partner

Robinson+Cole’s partnership has elected Boston Business Transactions Partner J. Michael Wirvin as its next Managing Partner, marking a pivotal moment in the firm’s 180-year history. Effective March 1, Wirvin will become the firm’s first Managing Partner based outside of Hartford, CT, reflecting Robinson+Cole’s continued evolution and expanding geographic footprint. His election underscores the firm’s deliberate, forward‑looking approach to leadership succession and long‑term strategic growth. Wirvin has served on Robinson+Cole’s Managing Committee since 2014, where he has played a central role in firm governance, strategic planning, and leadership succession, working closely with three managing partners through periods of unprecedented growth, market expansion, and changes in the legal industry. He is widely recognized for advising clients on complex domestic and cross‑border mergers and acquisitions, financings, and corporate structuring matters, with a particular focus on assisting U.S. and offshore companies navigate the legal, commercial, and cultural complexities of operating across jurisdictions. Wirvin also co‑chairs the firm’s International team. Wirvin has served as partner-in-charge of Robinson+Cole’s Boston office since 2014, reinforcing the firm’s culture, mentoring lawyers at all stages of their careers, and fostering cross‑disciplinary teamwork that strengthens client service. He recently helped lead the relocation of Robinson+Cole’s Boston office to 53 State Street, a premier downtown tower, creating a modern, light‑filled space designed to support employee well‑being with an energizing environment along with enhanced technology and workspaces that facilitate seamless remote and on-site collaboration and team building, while also promoting focused work. “It is a profound honor to be elected by my partners to serve as Managing Partner and lead this extraordinary team of lawyers and business professionals who raise the bar every day,” said Wirvin. “Our 180-year history is defined not merely by longevity, but by the trust we have earned, the results we have delivered, and the professionalism, mutual respect, and collegiality that have long defined our culture. As Managing Partner, I aim to build on that foundation—bringing strategic clarity and disciplined growth to our priorities, strengthening our national and international profile, investing in our people, and ensuring Robinson+Cole remains agile, cohesive, and well positioned to deliver practical, business‑minded solutions for clients in an increasingly complex and competitive environment.” Wirvin succeeds Rhonda J. Tobin, the firm’s first female Managing Partner, who led Robinson+Cole since 2021 and guided the firm through a period of significant transformation, growth, and innovation. Elected during the height of the COVID‑19 pandemic, Tobin brought to the role more than a decade of firm leadership experience, including service on the Managing Committee for 17 years and leadership of the firm’s Litigation Section for 14 years. During Tobin’s five-year tenure, Robinson+Cole successfully advanced and executed on a new Strategic Plan, improving profitability; expanding the firm’s New York, Boston, and Philadelphia offices; opening and growing offices in Washington, DC, and Austin, TX; and deepening leading national practices in affordable housing finance, bankruptcy, business transactions, capital markets and securities, intellectual property and technology, health care, managed care litigation, immigration, insurance, public finance, and real estate and development. Under Tobin’s leadership, the firm also strengthened its commitment to collaboration, inclusion, and talent development; launched meaningful DEIB initiatives; and made significant investments in technology, information governance, and workplace innovation. Additionally, the firm achieved top national rankings in Vault’s Best Law Firms to Work For six consecutive years. Robinson+Cole became the first Am Law 200 firm to strategically partner with agentic AI builder Newcode.ai and the first law firm in the United States to earn ARMA’s Verified Organization status, further reinforcing its position as an industry leader in innovation and information governance. Tobin’s leadership has been widely recognized, including being named Regional Managing Partner of the Year in Law.com’s 2025 New England Legal Awards and Managing Partner of the Year in the 2022 Women, Influence & Power in Law Awards. She will continue to serve as chair of the firm’s lateral growth committee and will continue her leadership roles and active involvement in Connecticut’s non-profit community and as Chairperson of the Connecticut Judicial Review Council. Commenting on Wirvin’s election, Tobin stated, “Mike’s deeply rooted presence and extensive leadership experience at Robinson+Cole make him an outstanding choice to lead our firm. I have known and worked closely with Mike for more than two decades, and there is no question that he is the right person to guide us forward as technological advancements and an evolving professional landscape present new opportunities. Mike is an exceptionally talented and experienced lawyer, and a trusted confidant whose insight I consistently relied on when facing strategic decisions. He is deeply respected by our lawyers and business professionals and brings a thoughtful, strategic perspective that will greatly benefit the firm. I look forward to the firm’s continued growth and success under his leadership.” Robinson+Cole also announced several additional leadership updates reflecting the firm’s continued focus on thoughtful succession planning, geographic expansion, and strategic growth. Davis Lee Wright, who is based in the firm’s Wilmington office, has been elected to the Managing Committee, joining Britt‑Marie K. Cole‑Johnson and Edward J. Heath who are resident in the Hartford office, Eric M. Kogan in Stamford, and Charles F. Martin III in Miami. The firm recently named New York partner Erica J. Kerstein as chair of its Insurance + Reinsurance group, Stamford partner Patrick W. Begos co-chair of its Managed Care + ERISA Litigation group, and Hartford partners  Conor O. Duffy and Robert S. Melvin and as Health Law group co-chair and Land Law Section co-chair, respectively. In addition, Kendra L. Berardi will succeed Wirvin as partner in charge of the Boston office.

News
Robinson+Cole Recognized Across Practices and Regions with 46 Chambers USA 2026 Rankings
News
Robinson+Cole Expands National Platform with Four Lateral Partners

Robinson+Cole announced the addition of four lateral partners—J. Zachary Balasko, Eric Del Pozo, Brya M. Keilson and Victor R. Salgado, accelerating the firm’s continued investment in the growth of its national bankruptcy and business litigation capabilities. Balasko and Keilson join the firm’s Bankruptcy + Reorganizations group in Washington, DC, and Wilmington, DE, respectively, while Del Pozo and Salgado join the Business Litigation group in Hartford, CT, and Washington, DC. These strategic hires enhance the firm’s ability to serve clients navigating complex, high‑stakes bankruptcy, restructuring, government enforcement, and related litigation matters nationwide and expand the firm’s depth and reach across key markets. “These additions meaningfully reinforce the depth and versatility of our business litigation and restructuring platform and reflect a deliberate approach to strengthening these areas in ways that directly benefit our clients,” said J. Michael Wirvin, the firm’s Managing Partner. “Eric, Zak, Brya, and Victor each bring sophisticated experience and sound judgment that enhance our ability to advise clients through some of their most critical and challenging matters. Their arrival reflects our continued focus on building cohesive, multi-disciplinary teams with capabilities that extend across multiple markets.” J. Zachary Balasko joins the firm as a Bankruptcy + Reorganizations partner based in Washington, DC. His practice focuses on complex Chapter 11 cases and bankruptcy‑related litigation across the country, representing debtors, secured creditors, creditors’ committees, and governmental entities. Balasko brings substantial experience from both private practice and prior service with the U.S. Department of Justice, where he handled major insolvency matters involving federal interests. Eric Del Pozo joins Robinson+Cole’s Hartford, CT office as a Business Litigation partner focusing on complex commercial litigation and appellate matters, representing businesses and public entities in regulated industries in high-stakes and sophisticated disputes. Del Pozo brings experience from senior roles in government and private practice, where he has represented clients at both the trial and appellate levels. Brya Keilson joins Robinson+Cole as a Bankruptcy + Reorganizations partner in the firm’s Wilmington, DE office, one of the nation’s leading venues for complex bankruptcy proceeding . She represents debtors, creditors, committees, trustees, and other parties in interest in sophisticated Chapter 11 and Chapter 7 cases. Keilson is widely experienced in contested bankruptcy matters and frequently advises clients on both strategic and practical considerations throughout the restructuring process. Victor Salgado joins Robinson+Cole as a Business Litigation partner in the firm’s Washington, DC office. He brings significant experience from both government and private practice, including eight years as a federal prosecutor with the U.S. Department of Justice in Washington, DC, where he handled high‑profile and complex cases focusing on public corruption as well as crimes involving financial institutions. Salgado will also work closely with the firm’s Bankruptcy + Reorganizations group on contested matters arising in complex restructurings and related litigation. In addition, Destiney Parker-Thompson joins the firm as a Bankruptcy + Reorganizations associate in the Wilmington office. Parker‑Thompson focuses her practice on bankruptcy, restructuring, and related litigation matters, drawing on experience representing debtors, creditors, and financial institutions in complex Chapter 11 cases. She previously served as a judicial law clerk to the U.S. Bankruptcy Court for the District of Delaware and the U.S. Court of Appeals for the Third Circuit, bringing valuable insight to sophisticated restructuring matters. Robinson+Cole’s Bankruptcy + Reorganizations group has recently been recognized for its role in several of the most complex and precedent‑setting restructuring matters in the country, earning multiple national honors for its work in high‑profile Chapter 11 cases and related litigation. The group has guided stakeholders through landmark proceedings—including award‑recognized reorganizations, a first‑of‑its‑kind bankruptcy confirmed with a Section 524(g) injunction, and other transformative restructurings—reflecting the team’s ability to deliver strategic, results‑driven counsel in matters with significant legal and financial implications.

News
Robinson+Cole Integrates Thomson Reuters’ Deep Research into Newcode.ai Platform to Advance Secure, Verifiable Legal Research

Robinson+Cole has expanded its firmwide artificial intelligence (AI) capabilities by integrating Thomson Reuters’ Deep Research directly into Newcode.ai, the agentic AI platform implemented last year by the firm to support legal workflows across practices. With this integration, Robinson+Cole is one of only two law firms with direct access to the Deep Research API—and the only firm deploying it through Newcode.ai. Building on its 2025 partnership with Newcode.ai —making Robinson+Cole the first Am Law 200 firm to adopt the platform—the firm has continued to expand its AI capabilities as part of a broader strategy focused on secure deployment, ethical use, and seamless integration into daily legal work. The integration enables Robinson+Cole attorneys to conduct complex, multi‑step legal research and receive verifiable, citation‑backed responses grounded in trusted Thomson Reuters content. By embedding Deep Research into Newcode.ai, Robinson+Cole continues to build on its deliberate, governance‑first approach to AI adoption while delivering meaningful, practice‑ready innovation for its lawyers and clients. “Innovation at Robinson+Cole is grounded in client service, security, and practicality,” said J. Michael Wirvin, Managing Partner of Robinson+Cole. “By incorporating Thomson Reuters’ Deep Research directly into Newcode.ai, we are providing our lawyers with advanced research capabilities in a secure environment fully controlled by the firm that aligns with our standards for data governance, accuracy, and responsible AI use. This integration reflects our continued focus on adopting technology thoughtfully to support our attorneys and deliver value to our clients.” The addition of Deep Research allows attorneys to: Perform sophisticated legal research using agentic workflows that mirror real‑world legal reasoning Receive structured, verifiable responses grounded in Thomson Reuters data Streamline research processes while maintaining rigorous quality and accuracy standards Work entirely within Robinson+Cole’s firm‑controlled AI environment  “Our integration of the Thomson Reuters’ Deep Research API with Newcode represents a defining moment in our AI strategy,” said Chief Data Officer Jim Merrifield. "We are incredibly proud to be the first firm to bring this capability to life—unlocking the power of trusted legal data directly within the workflows our lawyers and business professionals rely on every day. This is exactly how we maximize our technology investments: by connecting best-in-class data sources through APIs into a unified platform, so the technology meets our people where they work, enhances their judgment, and accelerates better outcomes for our clients.” Robinson+Cole’s AI program is guided by firmwide policies, mandatory training, and ongoing oversight to ensure responsible use of emerging technologies. The firm’s approach emphasizes measured adoption, strong information governance, and alignment with client expectations, rather than one‑off experimentation. This latest enhancement underscores Robinson+Cole’s commitment to remaining forward‑thinking in its use of technology, while ensuring that innovation serves the firm’s clients, lawyers, and long‑term strategic goals.

News
Robinson+Cole’s People-First Culture Recognized in Vault’s 2027 Rankings
News
Robinson+Cole Recognized at 2026 Women, Influence & Power in Law Awards
News
Julianna Charpentier Recognized as an “Up & Coming Lawyer”
News
Erica Kerstein Brings Credibility and Business Perspective to New Role as Practice Group Chair

Insurance + Reinsurance group chair Erica J. Kerstein was featured in a Law.com column titled, “How I Made Practice Group Chair,” published on April 15, 2026. In the article, Erica discusses her new role as a practice group chair and how it has expanded her insight into not only the firm’s strategic vision and goals, but the reality of running a business and ensuring that current planning aligns with future goals. “The role provides a window into how individual practices fit into the firm’s overall strategy,” said Erica. “You’re thinking not just about today’s matters, but about where clients are headed, how the industry is changing, and how the firm positions itself to meet those needs.” In addition, Erica also identified “…strengthening client relationships, investing in our people, and staying ahead of emerging issues—particularly around technology and artificial intelligence in the insurance space…” as key priorities for the practice. Read the article.

News
Robinson+Cole Remains A “Best Place to Work in Connecticut”
News
Kate Dion and Natale DiNatale Examine the Legal Questions Raised By Sorsby Injunction

Education industry team chair Kathleen Dion and Labor Relations group chair Natale DiNatale discussed the potential ramifications on the NCAA and college athletes in the article, “NCAA to appeal Brendan Sorsby injunction. What it means and how it can win,” published in USA Today, June 8, 2026. Kate pointed out that the injunction is a temporary measure. “This decision is only a preliminary ruling and is subject to appeal. Unless it is overturned, the injunction preserves Sorsby’s opportunity to compete this fall while the underlying case proceeds and allows him to continue preparing for a potential NFL career. For the NCAA, the ruling raises questions about the extent to which courts may review and potentially limit the enforcement of eligibility and competitive-integrity rules in individual cases.”  She continued, “It is also important to recognize that this is one state trial court decision, not a final decision on the merits, and thus its precedential value may be limited. While the court found that Sorsby demonstrated a probable right to the relief that he seeks on his breach of contract and other claims, which is a necessary element for obtaining a temporary injunction — the order does not appear to provide a detailed explanation of the court’s reasoning on that issue. As a result, many of the legal questions raised by the case are likely to remain the subject of further litigation and possible appellate review.” Discussing the foundation of the claim, Natale said, “The underlying dispute looks like a claim that the NCAA failed to accommodate a disability (e.g. an ADA claim based on a gambling addiction). But, it was brought as a breach of contract claim. A contract claim can be brought and maybe kept, in state court, which is likely a friendlier forum for this athlete.” Read the article.

News
Robinson+Cole Names J. Michael Wirvin as Managing Partner

Robinson+Cole’s partnership has elected Boston Business Transactions Partner J. Michael Wirvin as its next Managing Partner, marking a pivotal moment in the firm’s 180-year history. Effective March 1, Wirvin will become the firm’s first Managing Partner based outside of Hartford, CT, reflecting Robinson+Cole’s continued evolution and expanding geographic footprint. His election underscores the firm’s deliberate, forward‑looking approach to leadership succession and long‑term strategic growth. Wirvin has served on Robinson+Cole’s Managing Committee since 2014, where he has played a central role in firm governance, strategic planning, and leadership succession, working closely with three managing partners through periods of unprecedented growth, market expansion, and changes in the legal industry. He is widely recognized for advising clients on complex domestic and cross‑border mergers and acquisitions, financings, and corporate structuring matters, with a particular focus on assisting U.S. and offshore companies navigate the legal, commercial, and cultural complexities of operating across jurisdictions. Wirvin also co‑chairs the firm’s International team. Wirvin has served as partner-in-charge of Robinson+Cole’s Boston office since 2014, reinforcing the firm’s culture, mentoring lawyers at all stages of their careers, and fostering cross‑disciplinary teamwork that strengthens client service. He recently helped lead the relocation of Robinson+Cole’s Boston office to 53 State Street, a premier downtown tower, creating a modern, light‑filled space designed to support employee well‑being with an energizing environment along with enhanced technology and workspaces that facilitate seamless remote and on-site collaboration and team building, while also promoting focused work. “It is a profound honor to be elected by my partners to serve as Managing Partner and lead this extraordinary team of lawyers and business professionals who raise the bar every day,” said Wirvin. “Our 180-year history is defined not merely by longevity, but by the trust we have earned, the results we have delivered, and the professionalism, mutual respect, and collegiality that have long defined our culture. As Managing Partner, I aim to build on that foundation—bringing strategic clarity and disciplined growth to our priorities, strengthening our national and international profile, investing in our people, and ensuring Robinson+Cole remains agile, cohesive, and well positioned to deliver practical, business‑minded solutions for clients in an increasingly complex and competitive environment.” Wirvin succeeds Rhonda J. Tobin, the firm’s first female Managing Partner, who led Robinson+Cole since 2021 and guided the firm through a period of significant transformation, growth, and innovation. Elected during the height of the COVID‑19 pandemic, Tobin brought to the role more than a decade of firm leadership experience, including service on the Managing Committee for 17 years and leadership of the firm’s Litigation Section for 14 years. During Tobin’s five-year tenure, Robinson+Cole successfully advanced and executed on a new Strategic Plan, improving profitability; expanding the firm’s New York, Boston, and Philadelphia offices; opening and growing offices in Washington, DC, and Austin, TX; and deepening leading national practices in affordable housing finance, bankruptcy, business transactions, capital markets and securities, intellectual property and technology, health care, managed care litigation, immigration, insurance, public finance, and real estate and development. Under Tobin’s leadership, the firm also strengthened its commitment to collaboration, inclusion, and talent development; launched meaningful DEIB initiatives; and made significant investments in technology, information governance, and workplace innovation. Additionally, the firm achieved top national rankings in Vault’s Best Law Firms to Work For six consecutive years. Robinson+Cole became the first Am Law 200 firm to strategically partner with agentic AI builder Newcode.ai and the first law firm in the United States to earn ARMA’s Verified Organization status, further reinforcing its position as an industry leader in innovation and information governance. Tobin’s leadership has been widely recognized, including being named Regional Managing Partner of the Year in Law.com’s 2025 New England Legal Awards and Managing Partner of the Year in the 2022 Women, Influence & Power in Law Awards. She will continue to serve as chair of the firm’s lateral growth committee and will continue her leadership roles and active involvement in Connecticut’s non-profit community and as Chairperson of the Connecticut Judicial Review Council. Commenting on Wirvin’s election, Tobin stated, “Mike’s deeply rooted presence and extensive leadership experience at Robinson+Cole make him an outstanding choice to lead our firm. I have known and worked closely with Mike for more than two decades, and there is no question that he is the right person to guide us forward as technological advancements and an evolving professional landscape present new opportunities. Mike is an exceptionally talented and experienced lawyer, and a trusted confidant whose insight I consistently relied on when facing strategic decisions. He is deeply respected by our lawyers and business professionals and brings a thoughtful, strategic perspective that will greatly benefit the firm. I look forward to the firm’s continued growth and success under his leadership.” Robinson+Cole also announced several additional leadership updates reflecting the firm’s continued focus on thoughtful succession planning, geographic expansion, and strategic growth. Davis Lee Wright, who is based in the firm’s Wilmington office, has been elected to the Managing Committee, joining Britt‑Marie K. Cole‑Johnson and Edward J. Heath who are resident in the Hartford office, Eric M. Kogan in Stamford, and Charles F. Martin III in Miami. The firm recently named New York partner Erica J. Kerstein as chair of its Insurance + Reinsurance group, Stamford partner Patrick W. Begos co-chair of its Managed Care + ERISA Litigation group, and Hartford partners  Conor O. Duffy and Robert S. Melvin and as Health Law group co-chair and Land Law Section co-chair, respectively. In addition, Kendra L. Berardi will succeed Wirvin as partner in charge of the Boston office.

News
Robinson+Cole Recognized Across Practices and Regions with 46 Chambers USA 2026 Rankings
News
Robinson+Cole Expands National Platform with Four Lateral Partners

Robinson+Cole announced the addition of four lateral partners—J. Zachary Balasko, Eric Del Pozo, Brya M. Keilson and Victor R. Salgado, accelerating the firm’s continued investment in the growth of its national bankruptcy and business litigation capabilities. Balasko and Keilson join the firm’s Bankruptcy + Reorganizations group in Washington, DC, and Wilmington, DE, respectively, while Del Pozo and Salgado join the Business Litigation group in Hartford, CT, and Washington, DC. These strategic hires enhance the firm’s ability to serve clients navigating complex, high‑stakes bankruptcy, restructuring, government enforcement, and related litigation matters nationwide and expand the firm’s depth and reach across key markets. “These additions meaningfully reinforce the depth and versatility of our business litigation and restructuring platform and reflect a deliberate approach to strengthening these areas in ways that directly benefit our clients,” said J. Michael Wirvin, the firm’s Managing Partner. “Eric, Zak, Brya, and Victor each bring sophisticated experience and sound judgment that enhance our ability to advise clients through some of their most critical and challenging matters. Their arrival reflects our continued focus on building cohesive, multi-disciplinary teams with capabilities that extend across multiple markets.” J. Zachary Balasko joins the firm as a Bankruptcy + Reorganizations partner based in Washington, DC. His practice focuses on complex Chapter 11 cases and bankruptcy‑related litigation across the country, representing debtors, secured creditors, creditors’ committees, and governmental entities. Balasko brings substantial experience from both private practice and prior service with the U.S. Department of Justice, where he handled major insolvency matters involving federal interests. Eric Del Pozo joins Robinson+Cole’s Hartford, CT office as a Business Litigation partner focusing on complex commercial litigation and appellate matters, representing businesses and public entities in regulated industries in high-stakes and sophisticated disputes. Del Pozo brings experience from senior roles in government and private practice, where he has represented clients at both the trial and appellate levels. Brya Keilson joins Robinson+Cole as a Bankruptcy + Reorganizations partner in the firm’s Wilmington, DE office, one of the nation’s leading venues for complex bankruptcy proceeding . She represents debtors, creditors, committees, trustees, and other parties in interest in sophisticated Chapter 11 and Chapter 7 cases. Keilson is widely experienced in contested bankruptcy matters and frequently advises clients on both strategic and practical considerations throughout the restructuring process. Victor Salgado joins Robinson+Cole as a Business Litigation partner in the firm’s Washington, DC office. He brings significant experience from both government and private practice, including eight years as a federal prosecutor with the U.S. Department of Justice in Washington, DC, where he handled high‑profile and complex cases focusing on public corruption as well as crimes involving financial institutions. Salgado will also work closely with the firm’s Bankruptcy + Reorganizations group on contested matters arising in complex restructurings and related litigation. In addition, Destiney Parker-Thompson joins the firm as a Bankruptcy + Reorganizations associate in the Wilmington office. Parker‑Thompson focuses her practice on bankruptcy, restructuring, and related litigation matters, drawing on experience representing debtors, creditors, and financial institutions in complex Chapter 11 cases. She previously served as a judicial law clerk to the U.S. Bankruptcy Court for the District of Delaware and the U.S. Court of Appeals for the Third Circuit, bringing valuable insight to sophisticated restructuring matters. Robinson+Cole’s Bankruptcy + Reorganizations group has recently been recognized for its role in several of the most complex and precedent‑setting restructuring matters in the country, earning multiple national honors for its work in high‑profile Chapter 11 cases and related litigation. The group has guided stakeholders through landmark proceedings—including award‑recognized reorganizations, a first‑of‑its‑kind bankruptcy confirmed with a Section 524(g) injunction, and other transformative restructurings—reflecting the team’s ability to deliver strategic, results‑driven counsel in matters with significant legal and financial implications.

News
Robinson+Cole Integrates Thomson Reuters’ Deep Research into Newcode.ai Platform to Advance Secure, Verifiable Legal Research

Robinson+Cole has expanded its firmwide artificial intelligence (AI) capabilities by integrating Thomson Reuters’ Deep Research directly into Newcode.ai, the agentic AI platform implemented last year by the firm to support legal workflows across practices. With this integration, Robinson+Cole is one of only two law firms with direct access to the Deep Research API—and the only firm deploying it through Newcode.ai. Building on its 2025 partnership with Newcode.ai —making Robinson+Cole the first Am Law 200 firm to adopt the platform—the firm has continued to expand its AI capabilities as part of a broader strategy focused on secure deployment, ethical use, and seamless integration into daily legal work. The integration enables Robinson+Cole attorneys to conduct complex, multi‑step legal research and receive verifiable, citation‑backed responses grounded in trusted Thomson Reuters content. By embedding Deep Research into Newcode.ai, Robinson+Cole continues to build on its deliberate, governance‑first approach to AI adoption while delivering meaningful, practice‑ready innovation for its lawyers and clients. “Innovation at Robinson+Cole is grounded in client service, security, and practicality,” said J. Michael Wirvin, Managing Partner of Robinson+Cole. “By incorporating Thomson Reuters’ Deep Research directly into Newcode.ai, we are providing our lawyers with advanced research capabilities in a secure environment fully controlled by the firm that aligns with our standards for data governance, accuracy, and responsible AI use. This integration reflects our continued focus on adopting technology thoughtfully to support our attorneys and deliver value to our clients.” The addition of Deep Research allows attorneys to: Perform sophisticated legal research using agentic workflows that mirror real‑world legal reasoning Receive structured, verifiable responses grounded in Thomson Reuters data Streamline research processes while maintaining rigorous quality and accuracy standards Work entirely within Robinson+Cole’s firm‑controlled AI environment  “Our integration of the Thomson Reuters’ Deep Research API with Newcode represents a defining moment in our AI strategy,” said Chief Data Officer Jim Merrifield. "We are incredibly proud to be the first firm to bring this capability to life—unlocking the power of trusted legal data directly within the workflows our lawyers and business professionals rely on every day. This is exactly how we maximize our technology investments: by connecting best-in-class data sources through APIs into a unified platform, so the technology meets our people where they work, enhances their judgment, and accelerates better outcomes for our clients.” Robinson+Cole’s AI program is guided by firmwide policies, mandatory training, and ongoing oversight to ensure responsible use of emerging technologies. The firm’s approach emphasizes measured adoption, strong information governance, and alignment with client expectations, rather than one‑off experimentation. This latest enhancement underscores Robinson+Cole’s commitment to remaining forward‑thinking in its use of technology, while ensuring that innovation serves the firm’s clients, lawyers, and long‑term strategic goals.

News
Robinson+Cole’s People-First Culture Recognized in Vault’s 2027 Rankings
News
Robinson+Cole Recognized at 2026 Women, Influence & Power in Law Awards